RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Neuro, I was also wondering if you had any opinion on a company called Pozen? Listening to their presentation at the recent Montreal Conference, their approach sounded interesting. They're combining the current migraine med Sumatriptan with the NSAID Naproxen within the same pill. Another product is a combination of Naproxen with an acid inhibitor (Omeprazole) in the same pill. This approach sounds so logical/simple/low risk, but I wonder how this combination approach might hold up from a patent perspective? Any other considerations which could limit this approach? Thanks for any insights.